The hippo-yes association protein pathway in liver cancer - Wikidata - awgldk - TriplyDB

The hippo-yes association protein pathway in liver cancer

The hippo-yes association protein pathway in liver cancer

http://www.wikidata.org/entity/Q37108727

about

Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis Diagnostic Performance of Des-γ-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-Analysis Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis Hepatitis C virus NS4B protein induces epithelial-mesenchymal transition by upregulation of Snail.Protective effect of astaxanthin on liver fibrosis through modulation of TGF-β1 expression and autophagy.Expression and clinical significance of YAP, TAZ, and AREG in hepatocellular carcinoma Golgi protein 73 as a biomarker for hepatocellular carcinoma: A diagnostic meta-analysis.Hippo signaling pathway in liver and pancreas: the potential drug target for tumor therapy.MicroRNA301 is a potential diagnostic biomarker for hepatocellular cancer.Inhibitive effects of 15-deoxy-Δ(12),(14)-prostaglandin J2 on hepatoma-cell proliferation through reactive oxygen species-mediated apoptosis By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice.Oncogenic role of the Notch pathway in primary liver cancer.The Hippo-Salvador signaling pathway regulates renal tubulointerstitial fibrosis.Lipopolysaccharide Induces Human Pulmonary Micro-Vascular Endothelial Apoptosis via the YAP Signaling Pathway.Combination therapy of ursodeoxycholic Acid and corticosteroids for primary biliary cirrhosis with features of autoimmune hepatitis: a meta-analysis.Hippo-YAP signaling pathway: A new paradigm for cancer therapy.MicroRNA-186 targets Yes-associated protein 1 to inhibit Hippo signaling and tumorigenesis in hepatocellular carcinoma.Markers of Hippo-Pathway Activity in Tumor Forming Liver Lesions.

P2860

Q26778511-43D0CC59-66C0-47C7-B858-A892187E1C2A Q26863560-0CB14401-43F8-414F-80CC-CEA5AE7B2C1F Q27023986-29102E0A-5F2E-481D-B078-316F31A74807 Q33588881-6FA894AF-F020-44B9-93BE-A02F9966C847 Q33594283-96ED393E-7610-4070-A6E0-C80D9E06B052 Q33594370-5963BCFB-6646-4366-82BA-FCAA2E3F1803 Q35159505-7D331CF4-3ACF-4ECB-8F23-0E87FF464E1A Q35484837-5AE3ECFD-59FA-491B-8E16-ED359A417AB9 Q35854289-AA213B70-CFD2-42AC-B484-9AA3608C9579 Q35868068-2ADB28E6-5B5C-4881-82BC-FDCD7C6267CE Q35955419-108C8AE6-ACEE-44C6-94DE-710476CA68BF Q37001697-C313EC57-6BA0-41CE-9166-77B9DFF7A967 Q37195589-53D0C9F4-23EC-47B5-877A-5F891772EC83 Q37348630-A591C4E9-3125-4D69-9AC7-FF662D848968 Q37402837-CD7F5C25-D2DE-4D2F-BF7D-A03666A1B51D Q38231786-8CA301A2-1F1B-4B2B-958F-D93F9885FC7F Q39654967-C79BF3CC-2AF1-4F24-9560-065EF24FEA21 Q51713474-4FC29D3F-0B7A-4ACF-9272-86440F285FA3

P2860

The hippo-yes association protein pathway in liver cancer

http://www.wikidata.org/entity/Q37108727

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The hippo-yes association protein pathway in liver cancer

@en

The hippo-yes association protein pathway in liver cancer.

@nl

type

label

The hippo-yes association protein pathway in liver cancer

@en

The hippo-yes association protein pathway in liver cancer.

@nl

prefLabel

The hippo-yes association protein pathway in liver cancer

@en

The hippo-yes association protein pathway in liver cancer.

@nl

P1433

Q37108727-61D8A6BF-84AE-4A97-88AB-67836909CFE2

P1476

Q37108727-4F7F5FF1-35B9-4295-9CDA-1E141D1A8007

P2093

Q37108727-0B6EDE68-2141-415E-B929-9DC1B4EA7851

Q37108727-1110077C-7D3F-45E0-ACBE-A673E216C585

Q37108727-1F42C248-0F59-4B9C-A2F3-6EE26F4599B6

Q37108727-49B37F59-D218-4232-95B4-D1DBFDCC5394

Q37108727-735EDE8A-E578-4AAD-8ED6-B246A14F15EE

Q37108727-A81E8456-19A6-4F3D-86E8-563C6BBACD57

Q37108727-E6D2D8E9-CE38-4332-A4F3-DD2B22887733

Q37108727-F1307BDA-F14A-4AA4-9D8F-B5C3FE00C1D0

P2860

Q37108727-041A3328-0A09-4D42-A59C-4F35F4B0B1E6

Q37108727-07D1C581-C87F-4C33-B645-9628FA55C95E

Q37108727-0854AC79-39C4-48B5-A958-970389AFB012

Q37108727-08FEF9CD-9288-4230-B688-72B72846196A

Q37108727-09C4384A-B5B0-45AF-8662-4A51B6BAE992

Q37108727-0BADD53F-20F1-4FA7-9EEE-316CCAC36013

Q37108727-21A7C04F-B34E-414C-9C84-F43636D88FFB

Q37108727-2A716A5D-576C-4BD4-8EF5-9F9494F1F2E5

Q37108727-2E100DD7-C0DE-447F-AD82-3C81F6F54C91

Q37108727-2F8CE702-4934-4AA8-8BF9-CEC3362FD5E1

P304

Q37108727-F91CEDA9-8170-49E8-B60D-3E2D66696BF4

P31

Q37108727-1E5ECB8B-E0E5-4895-AD91-990C6C9ACD88

P356

Q37108727-E59CC236-845F-49EB-B2D8-B52914D21E3F

P478

Q37108727-9DDFAE09-308C-4E8B-BFE8-71992C7E2F85

P577

Q37108727-F3CCB6FB-6A6B-45DE-A22D-157BD90DA37D

P5875

Q37108727-A73D5EC2-ABA7-447A-8613-9FCB2145CE73

P698

Q37108727-F3C0E1BD-6FC8-4947-98CC-83601DF5B060

P932

Q37108727-AE57FB0C-8AE3-4437-B8FE-2AE228EE9B94

P356

P1433

Gastroenterology research and practice

P1476

The hippo-yes association protein pathway in liver cancer

@en

P2093

Cheng Ping

http://www.w3.org/2001/XMLSchema#string

Dai Weiqi

http://www.w3.org/2001/XMLSchema#string

Guo Chuanyong

http://www.w3.org/2001/XMLSchema#string

Lu Jie

http://www.w3.org/2001/XMLSchema#string

Shen Miao

http://www.w3.org/2001/XMLSchema#string

Wang Fan

http://www.w3.org/2001/XMLSchema#string

Xu Ling

http://www.w3.org/2001/XMLSchema#string

Zhou Yingqun

http://www.w3.org/2001/XMLSchema#string

P2860

TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control

Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein

TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal

α-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1

Expression of Yes-associated protein in common solid tumors

Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon

Opposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP

Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver

YAP1 increases organ size and expands undifferentiated progenitor cells

P304

187070

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/187070

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256202135

http://www.w3.org/2001/XMLSchema#string

P698

23986776

http://www.w3.org/2001/XMLSchema#string

P932

3748736

http://www.w3.org/2001/XMLSchema#string